Caffeine

Caffeine is a methylxanthine CNS stimulant that antagonises adenosine receptors, used pharmaceutically in combination analgesics, as a neonatal apnoea therapy (citrated form), and as a performance-enhancing nutraceutical. Simson Pharma's Caffeine reference standard and impurities support compendial testing across these diverse pharmaceutical and nutraceutical applications.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Caffeine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Caffeine
Caffeine EP Impurity F
Caffeine EP Impurity E
Caffeidine Nitrate Impurity
Caffeine EP Impurity E Hydrochloride
Caffeine EP Impurity C
1,3-Dimethyluric Acid
Caffeine Impurity 8
N-(6-Amino-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acetamide
6-Amino-5-(N-formyl-N-methyl)-3-methyluracil
4-Amino-1,3-dimethyl-2,6-dioxy-5-nitrosopyrimidine
Caffeine Citrate
N1-Methylguanosine
N-Nitroso Caffeine Impurity 1
Mononitroso Caffeidine
Dinitroso Caffeidine
Caffeine Impurity 4 Sodium Salt
N-Nitroso Caffeine Impurity 3
N-Nitroso Caffeine Impurity 4
N-Nitroso Caffeine Impurity 6
N-Nitroso Caffeine Impurity 2
N-Nitroso Caffeine Impurity 5
Caffeine Impurity 1

Metabolites

Methylliberine

Isotope Labelled Compounds

Caffeine-D3
Paraxanthine-d6
Paraxanthine-D3
Caffeine-Trimethyl-13C3
Caffeine D9